PLEASE WATCH THIS--A cure for cancer!

[CJsKee]

Free viewing extended until further notice.

Burzynski: Cancer Is Serious Business on Vimeo

 

[rothenbj]

Back from the dead, a We the People request was started and got the 25k signatures required. The response-

OFFICIAL FOOD AND DRUG ADMINSTRATION RESPONSE TO
Antineoplastons, cancer drugs in FDA trials since 1995, results publicly audited by Congress, to gain final FDA-approval
Protecting Public Health Through Safe and Effective Treatments
By Janet Woodcock

Thank you for your petition asking the Obama Administration to accelerate the approval of antineoplastons for the treatment of cancer.

As you know, cancer treatments go through a careful research process to prove that they are safe and effective. The National Cancer Institute (NCI) has recommended that controlled clinical studies be conducted in order to assess the safety and efficacy of the therapy. To date no randomized, controlled trials showing the effectiveness of antineoplastons have been published in peer-reviewed scientific journals nor have all of the trials needed to approve antineoplastons as a treatment for cancer been conducted.

The timely review and approval of safe and effective new treatments are central to the U.S. Food and Drug Administration's (FDA) mission to protect and promote the public health. In fact, over the past 12 months, FDA approved 35 new medicines, including three cancer drugs that were approved in less than six months. This is among the highest number of approvals in the past decade. Many of the drugs are important advances for patients, including: two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin's lymphoma in 30 years; and the first new drug for lupus in 50 years. The approvals came while drug safety standards have been maintained.

A report released last month by FDA, FY 2011 Innovative Drug Approvals, shows faster approval times in the United States when compared to the FDA's counterparts around the globe. Of the 35 approvals in FY 2011, 24 occurred in the United States before any other country in the world, and also before the European Union, continuing a trend of the United States leading the world in first approval of new medicines.

The Administration remains committed to the timely approval of safe and effective drugs to improve the treatment of cancer and other illnesses.

Janet Woodcock is the Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration.

Sixteen years and it appears they are far from FDA approval and apparently their trying to take Dr Burzynski's medical license away in Texas early next year which would kill their efforts with the FDA. aT LEAST THE fda is proud of their 35 approvals this year. They are listed below-


Drug Name Drug Company/Companies
Adcetris Seattle Genetics, Inc
Anascorp Rare Disease Therapeutics, Inc.
Arcapta Neohaler Novartis Pharmaceuticals Corp
Ardovax Teva Women’s Health
Benlysta Human Genome Sciences GlaxoSmithKline
Brilinta AstraZeneca
Caprelsa AstraZeneca Pharmaceuticals
Corifact CSL Behring
Daliresp Forest Pharmaceuticals
DaTscan GE Healthcare, Inc
Dificid Optimer Pharmaceuticals.
Edarbi Takeda Pharmaceuticals.
Edurant Tibotec Therapeutics Centocor Ortho Biotech
Egrifta. Theratechnologies Inc
Firazyr Shire Human Genetic Therapies Inc.
Gadavist Bayer Pharmaceuticals
Halaven Eisai Co
Horizant GlaxoSmithKline
Incivek Vertex Pharmaceuticals
Latuda Sunovian Pharm, Inc
LaViv Fibrocell Technologies
Natroba ParaPRO
Nulojix Bristol-Myers Squibb
Potiga Valeant Pharmaceuticals North America GlaxoSmithKline
Pradaxa Boehringer Ingelheim Pharm
Spherusol Allermed Laboratories
Teflaro Forest Laboratories Cerexa, Inc
Tradjenta Boehringer Ingelheim Pharmaceuticals.
Viibryd PGxHealth
Victrelis Merck
Xalkori Pfizer Abbott Molecular
Xarelto Janssen Pharmaceuticals Johnson & Johnson
Yervoy. Bristol-Myers Squibb
Zelboraf Genentech, a member of the Roche Group
Zytiga Centocor Ortho Biotech Inc. Johnson & Johnson Europe


Spread the wealth

 

[sqirl1]

Back from the dead, a We the People request was started and got the 25k signatures required. The response-



Sixteen years and it appears they are far from FDA approval and apparently their trying to take Dr Burzynski's medical license away in Texas early next year which would kill their efforts with the FDA. aT LEAST THE fda is proud of their 35 approvals this year. They are listed below-


Drug Name Drug Company/Companies
Adcetris Seattle Genetics, Inc
Anascorp Rare Disease Therapeutics, Inc.
Arcapta Neohaler Novartis Pharmaceuticals Corp
Ardovax Teva Women’s Health
Benlysta Human Genome Sciences GlaxoSmithKline
Brilinta AstraZeneca
Caprelsa AstraZeneca Pharmaceuticals
Corifact CSL Behring
Daliresp Forest Pharmaceuticals
DaTscan GE Healthcare, Inc
Dificid Optimer Pharmaceuticals.
Edarbi Takeda Pharmaceuticals.
Edurant Tibotec Therapeutics Centocor Ortho Biotech
Egrifta. Theratechnologies Inc
Firazyr Shire Human Genetic Therapies Inc.
Gadavist Bayer Pharmaceuticals
Halaven Eisai Co
Horizant GlaxoSmithKline
Incivek Vertex Pharmaceuticals
Latuda Sunovian Pharm, Inc
LaViv Fibrocell Technologies
Natroba ParaPRO
Nulojix Bristol-Myers Squibb
Potiga Valeant Pharmaceuticals North America GlaxoSmithKline
Pradaxa Boehringer Ingelheim Pharm
Spherusol Allermed Laboratories
Teflaro Forest Laboratories Cerexa, Inc
Tradjenta Boehringer Ingelheim Pharmaceuticals.
Viibryd PGxHealth
Victrelis Merck
Xalkori Pfizer Abbott Molecular
Xarelto Janssen Pharmaceuticals Johnson & Johnson
Yervoy. Bristol-Myers Squibb
Zelboraf Genentech, a member of the Roche Group
Zytiga Centocor Ortho Biotech Inc. Johnson & Johnson Europe


Spread the wealth

what do they (supposedly) do?

 

[rothenbj]

sqirl, they do what all drugs do, make money for their push,,,, er, marketers. Pay attention to the TV commercials, they'll let you know.

 

[Vocalek]

The roadblock might be right here:

To date no randomized, controlled trials showing the effectiveness of antineoplastons have been published in peer-reviewed scientific journals nor have all of the trials needed to approve antineoplastons as a treatment for cancer been conducted.

If the peer-reviewed journals happen to be under the control of big pharma, Berzynski's results will never be published. We see the same thing in the tobacco control world. Many of the journals refuse to publish research reports that show anything positive about tobacco products.

I don't think that publication should be a requirement. The FDA should conduct its own reviews of the test results and not depend on the opinions of the researchers' peers, who might have their own ax to grind.

OK, call me "cynical." I didn't use to be until I stopped smoking by using e-cigarettes and then found out those caring people at the FDA wanted to ban them.

 

[MTV]

that is just straight up...CRIMINAL...thanks US government and the FDA/Pharma...hope you enjoy your time in hell

 

[rothenbj]

Berzynski just needs to partner with one of the big guys and I'm sure peer review would no longer be an issue.